Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis. - Wikidata - wikimedia - TriplyDB

Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis.

Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis.

http://www.wikidata.org/entity/Q46833326

about

Dialysis Patients with Implanted Drug-Eluting Stents Have Lower Major Cardiac Events and Mortality than Those with Implanted Bare-Metal Stents: A Taiwanese Nationwide Cohort Study Comparison of outcome in 1809 patients treated with drug-eluting stents or bare-metal stents in a real-world setting.Cardiac survival after pre-emptive coronary angiography in transplant patients and those awaiting transplantation Pharmacological and non pharmacological strategies in the management of coronary artery disease and chronic kidney disease Drug-Eluting Versus Bare-Metal Stents During PCI in Patients With End-Stage Renal Disease on Dialysis Cilostazol improves long-term patency after percutaneous transluminal angioplasty in hemodialysis patients with peripheral artery disease.Long-term survival and repeat coronary revascularization in dialysis patients after surgical and percutaneous coronary revascularization with drug-eluting and bare metal stents in the United States.Use of drug-eluting stents in patients with coronary artery disease and renal insufficiency.Management of coronary artery disease in end-stage renal disease.Percutaneous coronary intervention versus coronary artery bypass graft in chronic kidney disease: Optimal treatment options.Early and late outcomes of coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stents for dialysis patients.Management of cardiovascular disease in patients with kidney disease.How to balance risks and benefits in the management of CKD patients with coronary artery disease.One-year clinical outcomes of patients implanted with a Resolute Onyx™ zotarolimus-eluting stent.Coronary Revascularization in Patients with CKD Stage 5D: Pragmatic Considerations.Comparison of Drug-Eluting and Bare Metal Stents in Patients With Chronic Kidney Disease: An Updated Systematic Review and Meta-Analysis Clinical outcome and its predictors in hemodialysis patients with critical limb ischemia undergoing endovascular therapy.Differences in tissue characterization of restenotic neointima between sirolimus-eluting stent and bare-metal stent: integrated backscatter intravascular ultrasound analysis for in-stent restenosis.Impact of Hemodialysis on Procedural Outcomes of Percutaneous Coronary Intervention for Chronic Total Occlusion: Insights From the Japanese Multicenter Registry.Japanese Society for Dialysis Therapy guidelines for management of cardiovascular diseases in patients on chronic hemodialysis.Treatment of symptomatic coronary artery disease in patients with end-stage renal disease on hemodialysis with paclitaxel-eluting TAXUS stent.Cardiovascular Disease in Patients with End-Stage Renal Disease on Hemodialysis.Current Management of In-Stent Restenosis.Cardiovascular Outcomes in Patients on Hemodialysis following Drug-Eluting versus Bare-Metal Coronary Stents.

P2860

Q28552391-DA9ADFEB-42C9-4A35-9E33-7D31E8870433 Q35610691-F3732A3D-F14D-40DF-8D7C-A2433F2A06FF Q35985749-83A2D8E2-6EC7-43E7-AC89-CD5415E5A6BF Q36021782-84B1F7D3-5EB2-4F97-83D6-4D6C4C840E5F Q36730186-2392E615-D2D4-4852-93B9-76DC0778E7B5 Q36736604-50BB04A8-BDBE-4E3C-A364-DB78E9339286 Q37156325-F28EA467-7E04-47B1-BD8F-2A43937AFEDB Q37684624-6CB3ACAF-3CC4-425A-B0EB-C0FE61749A58 Q37929849-98447B23-2C42-4C92-AFFD-EE9B031D8A97 Q37957417-CDB1E15A-B8C6-4968-8C32-DF8344B38622 Q38002475-73DAA330-16AF-487C-970C-952482AD05CE Q38082646-93DA9471-9580-4635-B9A3-FA0F4DCFB74C Q38364890-E131B628-CCCE-49E1-BC0B-48824E0612C8 Q38652086-75FCE1B3-AE9A-4D41-BD1E-FD370C9D83D3 Q38834281-9D8C4274-F395-49A7-A981-FB31AFC3AE5A Q39002138-6713B6DF-3747-4142-A9C5-F848752359BC Q40180514-F0528F55-DE72-4E7F-BBE0-9EC9ABA06D9F Q43719381-889ECEB6-7850-4A9F-BE27-91DCB6AEF66E Q47161487-DABAAC9B-3CF9-4994-A5FD-D725E07395DD Q50502242-F50DB32C-4B65-4389-8C35-0A66D1C622F3 Q53347229-52F536CD-403B-4BA4-BC23-7222FA45476E Q54973184-368E7F2D-5A02-4C54-AD36-5EA9A1C67B4F Q55005923-BAE6209F-C115-435B-B9EC-A467580F6CD2 Q55260543-D10915E0-D12A-4ECD-9432-AEA3A4515B69

P2860

Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis.

http://www.wikidata.org/entity/Q46833326

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Sirolimus-eluting stents vs ba ...... renal failure on hemodialysis.

@en

Sirolimus-eluting stents vs ba ...... renal failure on hemodialysis.

@nl

type

label

Sirolimus-eluting stents vs ba ...... renal failure on hemodialysis.

@en

Sirolimus-eluting stents vs ba ...... renal failure on hemodialysis.

@nl

prefLabel

Sirolimus-eluting stents vs ba ...... renal failure on hemodialysis.

@en

Sirolimus-eluting stents vs ba ...... renal failure on hemodialysis.

@nl

P1433

Q46833326-F49705EB-180E-49BE-B2F7-7067D6E4D58B

P1476

Q46833326-BB120CAB-BFA9-4BA9-9EED-A6F870409B71

P2093

Q46833326-04B9BE69-FAE5-40F1-9FEB-D98DD0F4D6BA

Q46833326-060F490F-8B2B-4183-AE05-C9896ABFFADC

Q46833326-30019722-C511-458C-B691-D64D07ABDAF4

Q46833326-335E8F45-F860-4425-8118-6A1CBD34F18C

Q46833326-403AD3D3-ADF7-4F0E-A105-3BD9C594D9DA

Q46833326-6534A292-26ED-4082-83E0-A03F55B44403

Q46833326-6A1FE0F5-3E71-4F16-B7D4-E4A9F1D4291B

Q46833326-8DB4FED4-9A53-4C43-A072-7642F3D4F052

Q46833326-BE9C50E4-1FC4-43DF-B279-01C26F20CE67

Q46833326-C8D9F508-6BF6-4317-A184-F21E317F1E58

P304

Q46833326-152CDAEE-FCEF-445E-A086-D80D1091C3DC

P31

Q46833326-B46596DD-8606-40AB-9EE6-4FB080325DE7

P356

Q46833326-82DB21BF-CFE8-40F5-973B-AD1666444C92

P433

Q46833326-BB3FFE5D-6100-496A-A528-4C3F82BFFC39

P478

Q46833326-EE9486FD-3D13-48C4-97CF-BF36BD85F5E1

P50

Q46833326-980F8553-3914-46CD-B362-AD837ED446C6

Q46833326-C3CFB3D5-CB7B-4180-8609-2EC4A9983BCF

P577

Q46833326-10F74350-5845-4963-87E9-55D95B32D797

P698

Q46833326-93A943D4-AD60-488C-B2CA-74624E27DEC9

P356

P1433

Circulation Journal

P1476

Sirolimus-eluting stents vs ba ...... renal failure on hemodialysis

@en

P2093

Hiroshi Takahashi

http://www.w3.org/2001/XMLSchema#string

Ryuichiro Murakami

http://www.w3.org/2001/XMLSchema#string

Seiichi Matsuo

http://www.w3.org/2001/XMLSchema#string

Shoichi Maruyama

http://www.w3.org/2001/XMLSchema#string

Tadayuki Uetani

http://www.w3.org/2001/XMLSchema#string

Takanobu Toriyama

http://www.w3.org/2001/XMLSchema#string

Tatsuaki Matsubara

http://www.w3.org/2001/XMLSchema#string

Tetsuya Amano

http://www.w3.org/2001/XMLSchema#string

Toru Aoyama

http://www.w3.org/2001/XMLSchema#string

Toyoaki Murohara

http://www.w3.org/2001/XMLSchema#string

P304

56-60

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1253/CIRCJ.72.56

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P50

Hirotake Kasuga

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18159100

http://www.w3.org/2001/XMLSchema#string